Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization

This publication has 63 references indexed in Scilit:

• Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase
  Biochemical and Biophysical Research Communications, 2010
• Human Cytochrome P450 Oxidoreductase Deficiency Caused by the Y181D Mutation: Molecular Consequences and Rescue of Defect
  Drug Metabolism and Disposition, 2010
• Oligomerization Is Crucial for the Stability and Function of Heme Oxygenase-1 in the Endoplasmic Reticulum
  Journal of Biological Chemistry, 2009
• Measurement of Membrane-Bound Human Heme Oxygenase-1 Activity Using a Chemically Defined Assay System
  Drug Metabolism and Disposition, 2009
• Heme oxygenase-1: from biology to therapeutic potential
  Trends in Molecular Medicine, 2009
• C-Terminal Membrane Spanning Region of Human Heme Oxygenase-1 Mediates a Time-Dependent Complex Formation with Cytochrome P450 Reductase
  Biochemistry, 2008
• Pharmacological and Clinical Aspects of Heme Oxygenase
  Pharmacological Reviews, 2008
• Quantitation of heme oxygenase 1: Heme titration increases yield of purified protein
  Analytical Biochemistry, 2008
• Expression and Characterization of Full-Length Human Heme Oxygenase-1: The Presence of Intact Membrane-Binding Region Leads to Increased Binding Affinity for NADPH Cytochrome P450 Reductase
  Biochemistry, 2007
• Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
  Nature Medicine, 2002